The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The Microbiota Makes for Good Therapy: The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971 ) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that therapeutic responses may be improved via its modulation (13, 14)”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [14]
In the citing paper
“The P-ESC was considered representative of baseline microbiome data due to observations that the microbiome of patients treated with anti-PD-1, unlike anti-CTLA-4 or chemotherapy, is stable early after therapy initiation17–19.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [19]
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“In addition, broad-spectrum antibiotics (mainly beta-lactams) taken prior to immunotherapy markedly reduce the clinical benefit of ICIs, chimeric antigen receptor (CAR)-T cells, stem cell transplantation in patients, and immunogenic chemotherapy in preclinical tumor models.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [26]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Finally, monoassociation of tumor-bearing GF mice with SFB, which promotes Th17 cell differentiation in the LP (1, 13, 14) also had a detrimental impact on the tumor growthinhibitory effect of CTX (Fig.”
BackgroundImmunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · cited 1×
“Some antineoplastic agents mediate part of their anticancer activity by stimulating anticancer immune responses (6).”
BackgroundSelf-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“S6A) and is required for the therapeutic success of anticancer chemotherapies in several tumor models (19).”
BackgroundSelf-citationInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Self-citation
Research works printed but not linked: 1
- 10.1073/pnas.1113744109 · DOI · Paper page
Cited by
Items 501–600 of 1,012
Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
Yu, S. J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108387 · Cited by 73
Bifidobacterium modulation of tumor immunotherapy and its mechanism
Pei, B., Peng, S., Huang, C., & Zhou, F. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03665-x · Cited by 73
Gut microbiota and colorectal cancer
Yamamoto, M., & Matsumoto, S. (2016) · Genes and Environment · doi:10.1186/s41021-016-0038-8 · Cited by 80
The human microbiome and its link in prostate cancer risk and pathogenesis
Katongole, P., Sande, O. J., Joloba, M. L., Reynolds, S. J., & Niyonzima, N. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00319-2 · Cited by 75
Kuang, T., He, A., Lin, Y., Huang, X., Liu, L., & Zhou, L. (2020) · Aquaculture Reports · doi:10.1016/j.aqrep.2020.100501 · Cited by 71
Greathouse, K. L., Wyatt, M., Johnson, A. J., Toy, E. P., Khan, J., Dunn, K., Clegg, D. J., & Reddy, S. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100800 · Cited by 73
Dai, S., Chen, Y., Cai, W., Dong, S., Zhao, J., Chen, L., & Cheng, C. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01739-6 · Cited by 73
Harnessing the Microbiome to Enhance Cancer Immunotherapy
Nelson, M. H., Diven, M. A., Huff, L. W., & Paulos, C. M. (2015) · Journal of Immunology Research · doi:10.1155/2015/368736 · Cited by 79
Rogers, M. B., Aveson, V. G., Firek, B., Yeh, A., Brooks, B., Brower–Sinning, R., Steve, J., Banfield, J. F., Zureikat, A. H., Hogg, M. E., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000726 · Cited by 74
Connecting the Metabolic and Immune Responses to Cancer
Flint, T. R., Fearon, D. T., & Janowitz, T. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.001 · Cited by 72
Hylander, B. L., & Repasky, E. A. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1647356 · Cited by 77
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Chen, Y., Wu, F., Wu, P., Xing, H., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935846 · Cited by 75
New Insights into Graft-Versus-Host Disease and Graft Rejection
Perkey, E., & Maillard, I. P. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043720 · Cited by 75
Gebremeskel, S., Lobert, L. M., Tanner, K., Walker, B., Oliphant, T., Clarke, L. E., Dellaire, G., & Johnston, B. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0229 · Cited by 73
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Zhang, X., Liu, Q., Liao, Q., & Zhao, Y. (2020) · Journal of Cancer · doi:10.7150/jca.37445 · Cited by 75
Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
Hester, R., Mazur, P. K., & McAllister, F. M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0900 · Cited by 74
Dadgar-Zankbar, L., Elahi, Z., Shariati, A., Khaledi, A., Razavi, S., & Khoshbayan, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01909-y · Cited by 71
Wang, E., Yuan, Z., Wang, K., Gao, D., Liu, Z., & Liles, M. R. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.11.019 · Cited by 73
Gut Microbiome Modulates Response to Cancer Immunotherapy
Khan, M. A. W., Ologun, G. O., Arora, R., McQuade, J. L., & Wargo, J. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06111-x · Cited by 75
Elkrief, A., Méndez-Salazar, E. O., Maillou, J., Vanderbilt, C. M., Gogia, P., Desilets, A., Messaoudene, M., Kelly, D., Ladanyi, M., Hellmann, M. D., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00630-w · Cited by 68
“The addition of chemotherapy to IO could already disrupt gut microbiota and potentially make the impact of antibiotic exposure less clinically signi fi cant 20 .”
Self-citationIntestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
Bawaneh, A., Wilson, A. S., Levi, N., Howard-McNatt, M. M., Chiba, A., Soto‐Pantoja, D. R., & Cook, K. L. (2022) · Cancers · doi:10.3390/cancers14194849 · Cited by 71
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Amiri, M., Molavi, O., Sabetkam, S., Jafari, S., & Montazersaheb, S. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03058-7 · Cited by 74
The interplay between the microbiome and the adaptive immune response in cancer development
Russo, E., Taddei, A., Ringressi, M. N., Ricci, F., & Amedei, A. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16635082 · Cited by 74
Not Just Antibiotics: Is Cancer Chemotherapy Driving Antimicrobial Resistance?
Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.009 · Cited by 70
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Ding, C., Tang, W., Fan, X., & Wu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170626 · Cited by 69
Lauté-Caly, D. L., Raftis, E. J., Cowie, P., Hennessy, E., Holt, A., Panzica, D. A., Sparre, C., Minter, B., Stroobach, E., & Mulder, I. E. (2019) · Scientific Reports · doi:10.1038/s41598-018-36926-8 · Cited by 67
Understanding genomics and the immune environment of penile cancer to improve therapy
Aydın, A. M., Chahoud, J., Adashek, J. J., Azizi, M., Magliocco, A. M., Ross, J. S., Necchi, A., & Spiess, P. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0359-z · Cited by 70
Jaye, K. M., Li, C. G., & Bhuyan, D. J. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103429 · Cited by 69
Bernardo, G., Noci, V. L., Ottaviano, E., Cecco, L. D., Camisaschi, C., Guglielmetti, S., Modica, M. D., Gargari, G., Bianchi, F., Indino, S., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216041 · Cited by 69
Rébé, C., & Ghiringhelli, F. (2015) · Future Oncology · doi:10.2217/fon.15.198 · Cited by 72
Self-citationInfectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis
Diamanti, A. P., Rosado, M. M., & D’Amelio, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02696 · Cited by 72
Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model
Stehlíková, Z., Kostovcikova, K., Kverka, M., Rossmann, P., Dvořák, J., Novosádová, I., Kostovčík, M., Coufal, Š., Šrůtková, D., Procházková, P., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00236 · Cited by 67
The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
Wang, M., Yang, G., Tian, Y., Zhang, Q., Liu, Z., & Xin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183331 · Cited by 74
Broadening oncological boundaries: the intratumoral microbiota
Lu, Y.-Q., Qiao, H., Tan, X.-R., & Liu, N. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.01.007 · Cited by 66
Cao, C., Yue, S., Lü, A., & Liang, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107321 · Cited by 67
Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology
Patterson, A. D., & Turnbaugh, P. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.002 · Cited by 66
Pitt, J. M., Vétizou, M., Gomperts Boneca, I., Lepage, P., Chamaillard, M., & Zitvogel, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2015.1132137 · Cited by 64
Self-citationLiu, H., Li, J., Guo, X., Liang, Y., & Wang, W. (2018) · Microbial Biotechnology · doi:10.1111/1751-7915.13261 · Cited by 72
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
Wang, Y., Xie, W., Humeau, J., Chen, G., Liu, P., Pol, J., Zhang, Z., Kepp, O., & Kroemer, G. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000462 · Cited by 63
Self-citationConsiderations for successful cancer immunotherapy in aged hosts
Hurez, V, Padrón, Á. S., Svatek, R. S., & Curiel, T. J. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12875 · Cited by 65
Trial watch: Immunostimulatory cytokines in cancer therapy
Vacchelli, E., Aranda, F., Obrist, F., Eggermont, A., Galon, J., Cremer, I., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/onci.29030 · Cited by 64
Self-citationZhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 67
Robles‐Vera, I., Jarit-Cabanillas, A., Brandi, P., Martínez‐López, M., Martínez-Cano, S., Rodrigo-Tapias, M., Femenía-Muiña, M., Redondo‐Urzainqui, A., Nuñez, V., González‐Correa, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.12.012 · Cited by 69
The Microbiota, the Immune System and the Allograft
Alegre, M.-L., Mannon, R. B., & Mannon, P. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12760 · Cited by 69
Balló, O., Tarazzit, I., Stratmann, J., Reinheimer, C., Hogardt, M., Wichelhaus, T. A., Kempf, V. A. J., Serve, H. L., Finkelmeier, F., & Brandts, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210991 · Cited by 65
Bingula, R., Filaire, E., Molnar, I., Delmas, E., Berthon, J., Vasson, M., Bernalier‐Donadille, A., & Filaire, M. (2020) · Respiratory Research · doi:10.1186/s12931-020-01392-2 · Cited by 74
Zhu, H., He, Y., Ma, J., Zhou, J., Kong, M., Wu, C., Mao, Q., Lin, G., & Li, S.-L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113271 · Cited by 66
Probiotic species in the modulation of the anticancer immune response
Marinelli, L., Tenore, G. C., & Novellino, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.007 · Cited by 64
Microbiota transplantation: Targeting cancer treatment
Wu, X., Zhang, T., Chen, X., Ji, G., & Zhang, F. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.010 · Cited by 67
Nenclares, P., Bhide, S., Sandoval‐Insausti, H., Pialat, P.-M., Gunn, L., Melcher, A. A., Newbold, K. L., Nutting, C. M., & Harrington, K. J. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.02.047 · Cited by 64
Zeng, Z., Huang, Z., Yue, W., Nawaz, S., Chen, X., & Liu, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115812 · Cited by 65
Zeb2 drives invasive and microbiota-dependent colon carcinoma
Slowicka, K., Πέττα, Ι., Blancke, G., Hoste, E., Dumas, E., Sze, M., Vikkula, H., Radaelli, E., Haigh, J. J., Jonckheere, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0070-2 · Cited by 66
McQuade, J. L., Ologun, G. O., Arora, R., & Wargo, J. A. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00913-y · Cited by 63
Gut Microbiota in Lung Cancer: Where Do We Stand?
Georgiou, K. E., Marinov, B. I., Farooqi, A. A., & Gazouli, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910429 · Cited by 65
Xie, Z., Bai, Y., Chen, G., Dong, W., Peng, Y., Xu, W., Sun, Y., Zeng, X., & Liu, Z. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110901 · Cited by 63
Peiffer, L. B., White, J. R., Jones, C. B., Slottke, R., Ernst, S. E., Moran, A. E., Graff, J. N., & Sfanos, K. S. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100822 · Cited by 63
Locally sourced: site-specific immune barriers to metastasis
Correia, A. L. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00836-2 · Cited by 65
Zhao, L., Xing, C., Sun, W., Hou, G., Yang, G., & Yuan, L. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3691-8 · Cited by 64
Huo, W., Feng, Z., Hu, S., Cui, L., Qiao, T., Dai, L., Qi, P., Zhang, L., Liu, Y., & Li, J. (2020) · Food & Function · doi:10.1039/d0fo00597e · Cited by 64
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, M., Mulet-Margalef, N., Ochoa-de-Olza, M., Napoli, S., Mas-Lloret, J., Laquente, B., Alemany, L., Duell, E. J., Nuciforo, P. G., & Moreno, V. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031446 · Cited by 66
Microbiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 66
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
Cuozzo, M., Castelli, V., Avagliano, C., Cimini, A., d’Angelo, M., Cristiano, C., & Russo, R. (2021) · Biomedicines · doi:10.3390/biomedicines9040346 · Cited by 67
Glioma and the gut–brain axis: opportunities and future perspectives
Dono, A., Nickles, J., Rodriguez-Armendariz, A. G., McFarland, B. C., Ajami, N. J., Ballester, L. Y., Wargo, J. A., & Esquenazi, Y. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac054 · Cited by 68
T helper 17 (Th17) cell responses to the gut microbiota in human diseases
Sun, C., Yang, N. Y., Zheng, Z., Liu, D., & Xu, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114483 · Cited by 65
Intestinal microbiota-related effects on graft-versus-host disease
Shono, Y., Docampo, M. D., Peled, J. U., Perobelli, S. M., & Jenq, R. R. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1781-5 · Cited by 61
Wu, R., Mei, X., Ye, Y., Xue, T., Wang, J.-S., Sun, W., Lin, C., Xue, R., Zhang, J., & Xu, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104454 · Cited by 62
Prevotella copri is associated with carboplatin-induced gut toxicity
Yu, C., Zhou, B., Xia, X., Chen, S., Deng, Y., Wang, Y., Wu, L., Tian, Y., Zhao, B., Xu, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1963-9 · Cited by 66
Impact of the Gut Microbiome on Immune Checkpoint Inhibitor Efficacy—A Systematic Review
Pierrard, J., & Seront, E. (2019) · Current Oncology · doi:10.3747/co.26.5177 · Cited by 64
Roles of microbiota in response to cancer immunotherapy
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.026 · Cited by 65
Dutta, D., & Lim, S. H. (2020) · Biomarker Research · doi:10.1186/s40364-020-00211-6 · Cited by 64
Pilones, K. A., Hensler, M., Daviaud, C., Kraynak, J., Fucikova, J. P., Galluzzi, L., Demaria, S., & Formenti, S. C. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1830524 · Cited by 67
Pederzoli, F., Bandini, M., Raggi, D., Marandino, L., Basile, G., Alfano, M., Colombo, R., Salonia, A., Briganti, A., Gallina, A., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.05.018 · Cited by 61
The role of microbiome in pancreatic cancer
Li, J., Zhu, M., Kashyap, P., Chia, N., Tran, N. H., McWilliams, R. R., Bekaii‐Saab, T., & Ma, W. W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09982-2 · Cited by 66
Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
Noci, V. L., Bernardo, G., Bianchi, F., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732192 · Cited by 63
Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches
Dhurjad, P., Dhavaliker, C., Gupta, K., & Sonti, R. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000669 · Cited by 66
Whangbo, J., Ritz, J., & Bhatt, A. S. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.206 · Cited by 66
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
Groza, D., Gehrig, S., Kudela, P., Holcmann, M., Pirker, C., Dinhof, C., Schueffl, H. H., Sramko, M., Hoebart, J., Alioglu, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1424676 · Cited by 61
Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters
Dono, A., Patrizz, A., McCormack, R., Putluri, N., Ganesh, B. P., Kaur, B., McCullough, L. D., Ballester, L. Y., & Esquenazi, Y. (2020) · CNS Oncology · doi:10.2217/cns-2020-0007 · Cited by 64
The outstanding antitumor capacity of CD4+ T helper lymphocytes
Li, T., Wu, B., Yang, T., Zhang, L., & Jin, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188439 · Cited by 63
Novel strategies for modulating the gut microbiome for cancer therapy
Cho, Y. S., Han, K., Xu, J., & Moon, J. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115332 · Cited by 65
Immunomodulatory Effects of Lactobacillus Strains: Emphasis On Their Effects on Cancer Cells
Do, A. A., Taherian‐Esfahani, Z., Ghafouri‐Fard, S., Ghafouri-Fard, S., & Motevaseli, E. (2015) · Immunotherapy · doi:10.2217/imt.15.92 · Cited by 64
Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
Zama, D., Biagi, E., Masetti, R., Gasperini, P., Prete, A., Candela, M., Brigidi, P., & Pession, A. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.173 · Cited by 62
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 65
The systemic hallmarks of cancer
Paul, D. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.63 · Cited by 73
Crosstalk between circadian rhythms and the microbiota
Pearson, J. A., Wong, F. S., & Li, W. (2020) · Immunology · doi:10.1111/imm.13278 · Cited by 61
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Temraz, S. N., Nassar, F. J., Kreidieh, F., Mukherji, D., Shamseddine, A. I., & Nasr, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157800 · Cited by 62
Rong, Y., Dong, Z., Hong, Z., Jin, Y., Zhang, W., Zhang, B., Mao, W., Kong, H., Wang, C., Yang, B., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.07.009 · Cited by 59
Grgurević, I., Božin, T., Mikuš, M., Kukla, M., & O’Beirne, J. P. (2021) · Cancers · doi:10.3390/cancers13225844 · Cited by 61
Gut microbiota modulation: a tool for the management of colorectal cancer
Wang, Y., & Li, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03378-8 · Cited by 64
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 59
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang, S., Huang, J., Jiang, Z., Tong, H., Ma, X., & Liu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00248-9 · Cited by 63
Lipid metabolites as metabolic messengers in inter-organ communication
Liu, S., Alexander, R., & Lee, C. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.002 · Cited by 62
Tralau, T., Sowada, J., & Luch, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.990437 · Cited by 58
Gut microbiome as a novel cardiovascular therapeutic target
Singh, V., Yeoh, B. S., & Vijay–Kumar, M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.002 · Cited by 62
Pre-, pro- and synbiotics in cancer prevention and treatment—a review of basic and clinical research
Scott, A. J., Merrifield, C. A., Younes, J. A., & Pekelharing, E. P. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.869 · Cited by 62
Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
Yan, X., Zhang, S., Deng, Y., Wang, P., Hou, Q., & Xu, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01050 · Cited by 57
The Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
Metadata
- Authors
- Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P.-L., Eberl, G., Bérard, M., Ecobichon, C., Clermont, D., Bizet, C., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Opolon, P., Yessaad, N., Vivier, E., Ryffel, B., Elson, C. O., Doré, J., Kroemer, G., Lepage, P., Boneca, I. G., Ghiringhelli, F., & Zitvogel, L.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Harvard University (US)
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Agency for Science, Technology and Research (SG)
- Institut National de la Santé et de la Recherche Médicale, U866, Centre Georges François Leclerc, Dijon, France.
- Service de Microbiologie, Institut Gustave Roussy, Villejuif, France.
- Institut Gustave Roussy (FR)
- Institut Pasteur (FR)
- Nimalerie Centrale, Institut Pasteur, Paris, France.
- Institut National de la Recherche Agronomique, Micalis–UMR1319, 78350 Jouy-en-Josas, France.
- Centre National de la Recherche Scientifique (FR)
- Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université UM2, Marseille, France.
- Université d'Orléans (FR)
- University of Alabama at Birmingham (US)
- AgroParisTech (FR)
- Corresponding author
- Ghiringhelli, François
- Zitvogel, Laurence
- ORCID
- Mignot, Grégoire
- Yamazaki, Takahiro
- Daillère, Romain
- Hannani, Dalil
- Pfirschke, Christina
- Engblom, Camilla
- Schlitzer, Andreas
- Ginhoux, Florent
- Woerther, Paul-Louis
- Eberl, Gérard
- Clermont, Dominique
- Opolon, Paule
- Ryffel, Bernhard
- Elson, Charles O.
- Kroemer, Guido
- Lepage, Patricia
- Boneca, Ivo Gomperts
- Ghiringhelli, François
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2013-11-22
- Volume
- 342
- Issue
- 6161
- Pages
- 971-976
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4048947
- OpenAlex
- W2059128083
- Cited by
- 2,050
- References
- 43
- Citations by year
- 2026: 109 · 2025: 165 · 2024: 176 · 2023: 216 · 2022: 234 · 2021: 217 · 2020: 220 · 2019: 183 · 2018: 137 · 2017: 116 · 2016: 98 · 2015: 101 · 2014: 69 · 2013: 6
- FWCI
- 40.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- HAL AMU (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-11-PHUC-0002)
- National Cancer Institute (P50CA086355)
- National Institute of Allergy and Infectious Diseases (R01AI084880)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK071176)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- cyclophosphamide, gut microbiota, antitumor immunity, Gram-positive bacteria, Th17 cells, memory T cells, secondary lymphoid organs, bacterial translocation, germ-free mice, antibiotic therapy, adoptive transfer, small intestine
- MeSH terms
- Animals, Anti-Bacterial Agents, Antineoplastic Agents, Cyclophosphamide, Germ-Free Life, Gram-Positive Bacteria, Immunologic Memory, Immunosuppressive Agents, Intestine, Small, Lymphoid Tissue, Neoplasms, Bacterial Translocation, Adoptive Transfer, Mice, Th17 Cells, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.